Many patients with acoustic neuromas (ANs) have hearing function at diagnosis and desire to maintain it. To date, radiosurgical techniques have been focused on conformal irradiation of the tumor mass, with less attention to inner ear structures for which there was scant radiobiological information. The authors of this study evaluated tumor control and hearing preservation as they relate to tumor volume, imaging characteristics, and nerve and cochlear radiation dose following stereotactic radiosurgery (SRS) using the Gamma Knife.
Seventy-seven patients with ANs had serviceable hearing (Gardner-Robertson [GR] Class I or II) and underwent SRS between 2004 and 2007. This interval reflected more recent measurements of inner ear dosimetry during the authors' 21-year experience. The median patient age was 52 years (range 22–82 years). No patient had undergone any prior treatment for the ANs. The median tumor volume was 0.75 cm3(range 0.07–7.7 cm3), and the median radiation dose to the tumor margin was 12.5 Gy (range 12–13 Gy). At diagnosis, a greater distance from the lateral tumor to the end of the internal auditory canal correlated with better hearing function.
At a median of 20 months after SRS, no patient required any other additional treatment. Serviceable hearing was preserved in 71% of all patients and in 89% (46 patients) of those with GR Class I hearing. Significant prognostic factors for maintaining the same GR class included (all pre-SRS) GR Class I hearing, a speech discrimination score (SDS) ≥ 80%, a pure tone average (PTA) < 20 dB, and a patient age < 60 years. Significant prognostic factors for serviceable hearing preservation were (all pre-SRS) GR Class I hearing, an SDS ≥ 80%, a PTA < 20 dB, a patient age < 60 years, an intracanalicular tumor location, and a tumor volume < 0.75 cm3. Patients who received a radiation dose of < 4.2 Gy to the central cochlea had significantly better hearing preservation of the same GR class. Twelve of 12 patients < 60 years of age who had received a cochlear dose < 4.2 Gy retained serviceable hearing at 2 years post-SRS.
As currently practiced, SRS with the Gamma Knife preserves serviceable hearing in the majority of patients. Tumor volume and anatomy relate to the hearing level before radiosurgery and influence technique. A low radiosurgical dose to the cochlea enhances hearing preservation.
Please include this information when citing this paper: published online March 13, 2009; DOI: 10.3171/2008.12.JNS08611.
ChangSD,,GibbsIC,,SakamotoGT,,LeeE,,OyeleseA,&AdlerJRJr:Staged stereotactic irradiation for acoustic neuroma.开云体育app官方网站下载入口56:1254–1263,2005
ChopraR,,KondziolkaD,,NiranjanA,,LunsfordLD,&FlickingerJC:Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy.Int J Radiat Oncol Biol Phys68:845–851,2007
DelbrouckC,,HassidS,,MassagerN,,ChoufaniG,,DavidP,&DevriendtD,et al.:Preservation of hearing in vestibular schwannomas treated by radiosurgery using Leksell Gamma Knife: preliminary report of a prospective Belgian clinical study.Acta Otorhinolaryngol Belg57:197–204,2003
FlickingerJC,,KondziolkaD,,NiranjanA,&LundfordLD:Results of acoustic neuroma radiosurgery: an analysis of 5 years' experience using current methods.J Neurosurg94:1–6,2001
FlickingerJC,,KondziolkaD,,NiranjanA,,MaitzA,,签证官ynovG,&LunsfordLD:Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy.Int J Radiat Oncol Biol Phys60:225–230,2004
FlickingerJC,,KondziolkaD,,PollockBE,&LunsfordLD:Evolution of technique for vestibular schwannoma radiosurgery and effect on outcome.Int J Radiat Oncol Biol Phys36:275–280,1996
FussM,,DebusJ,,LohrF,,HuberP,,RheinB,&Engenhart-CabillicR,et al.:Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas.Int J Radiat Oncol Biol Phys48:1381–1387,2000
GardnerG,&RobertsonJH:Hearing preservation in unilateral acoustic neuroma surgery.Ann Otol Rhinol Laryngol97:55–66,1988
KarpinosM,,TehBS,,ZeckO,,CarpenterLS,,PhanC,&MaiWY,et al.:Treatment of acoustic neuroma: stereotactic radiosurgery vs. microsurgery.Int J Radiat Oncol Biol Phys54:1410–1421,2002
KondziolkaD,,LunsfordLD,,McLaughlinMR,&FlickingerJC:Long-term outcomes after radiosurgery for acoustic neuromas.N Engl J Med339:1426–1433,1998
三星WT,,DayJD,,MatulaC,&LevyDI:Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas.J Neurosurg88:506–512,1998
LapsiwalaSB,,PyleGM,,KaemmerleAW,,SasseFJ,&BadieB:Correlation between auditory function and internal auditory canal pressure in patients with vestibular schwannomas.J Neurosurg96:872–876,2002
LeeF,,LinthicumFJr,&HungG:Proliferation potential in recurrent acoustic schwannoma following gamma knife radiosurgery versus microsurgery.Laryngoscope112:948–950,2002
LevivierM,,MassagerN,&DavidP:radiosurge体内评价肿瘤反应ry: application to vestibular schwannomas.Neurochirurgie50:320–326,2004
LunsfordLD,,NiranjanA,,FlickingerJC,,MaitzA,&KondziolkaD:Radiosurgery of vestibular schwannomas: summary of experience in 829 cases.J Neurosurg102:195–199,2005
MassagerN,,NissimO,,DelbrouckC,,DerpierreI,,DevriendtD,&DesmedtF,et al.:Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome.J Neurosurg107:733–739,2007
MassagerN,,NissimO,,DelbrouckC,,DevriendtD,,DavidP,&DesmedtF,et al.:Role of intracanalicular volumetric and dosimetric parameters on hearing preservation after vestibular schwannoma radiosurgery.Int J Radiat Oncol Biol Phys64:1331–1340,2006
MeijerOWM,,VandertopWP,,BaayenJC,&SlotmanBJ:Singlefraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study.Int J Radiat Oncol Biol Phys56:1390–1396,2003
NeelyJG,&HoughJV:Histologic findings in two very small intracanalicular solitary schwannomas of the eighth nerve: II. “Onion bulbs”.Am J Otol9:216–221,1988
NiranjanA,,LunsfordLD,,FlickingerJC,,MaitzA,&KondziolkaD:Dose reduction improves hearing preservation rates after intracanalicular acoustic tumor radiosurgery.开云体育app官方网站下载入口45:753–765,1999
PaekSH,,ChungHT,,JeongSS,,ParkCK,,KimCY,&KimJE,et al.:Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma.Cancer104:580–590,2005
PollockBE,,DriscollCL,,FooteRL,,LinkMJ,,GormanDA,&BauchCD,et al.:Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery.开云体育app官方网站下载入口59:77–85,2006
SawamuraY,,ShiratoH,,SakamotoT,,AoyamaH,,SuzukiK,&OnimaruR,et al.:Management of vestibular schwannoma by fractionated stereotatic radiotherapy and associated cerebrospinal fluid malabsorption.J Neurosurg99:685–692,2003
SzumacherE,,SchwartzML,,TsaoM,,JaywantS,,FranssenE,&WongCS,et al.:Fractionated stereotactic radiotherapy for the treatment of vestibular schwannomas: combined experience of the Toronto-Sunnybrook Regional Cancer Centre and the Princess Margaret Hospital.Int J Radiat Oncol Biol Phys53:987–991,2002
VarlottoJM,,ShrieveDC,,AlexanderEIII,,KooyHM,,BlackPM,&LoefflerJS:Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas: preliminary results.Int J Radiat Oncol Biol Phys36:141–145,1996
YamakamiI,,UchinoY,,KobayashiE,&YamauraA:Conservative management, gamma-knife radiosurgery, and microsurgery for acoustic neurinomas: a systematic review of outcome and risk of three therapeutic options.神经Res25:682–690,2003
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 4179 | 1899 | 26 |
Full Text Views | 405 | 60 | 5 |
PDF Downloads | 347 | 72 | 10 |
EPUB Downloads | 0 | 0 | 0 |